Abstract:PKA (protein kinase A)–mediated phosphorylation of cardiac RyR2 (ryanodine receptor 2) has been extensively studied for decades, but the physiological significance of PKA phosphorylation of RyR2 remains poorly understood. Recent determination of high-resolution 3-dimensional structure of RyR2 in complex with CaM (calmodulin) reveals that the major PKA phosphorylation site in RyR2, serine-2030 (S2030), is located within a structural pathway of CaM-dependent inactivation of RyR2. This novel structural insight points to a possible role of PKA phosphorylation of RyR2 in CaM-dependent inactivation of RyR2, which underlies the termination of Ca 2+ release and induction of cardiac Ca 2+ alternans. To determine the role of the PKA phosphorylation site RyR2-S2030 in Ca 2+ release termination in vitro and cardiac Ca 2+ alternans in intact hearts. We performed single-cell endoplasmic reticulum Ca 2+ imaging to assess the impact of S2030 mutations on Ca 2+ release termination in HEK293 cells. We found that mutations, S2030D, S2030G, S2030L, S2030V, and S2030W reduced the endoplasmic reticulum luminal Ca 2+ level at which Ca 2+ release terminates (the termination threshold), whereas S2030P and S2030R increased the termination threshold. S2030A and S2030T had no significant impact on release termination. Furthermore, CaM–wild-type increased, whereas Ca 2+ binding deficient CaM mutant (CaM-M [a loss-of-function CaM mutation with all 4 EF-hand motifs mutated]), PKA, and Ca 2+ /CaMKII (CaM-dependent protein kinase II) reduced the termination threshold. The S2030L mutation abolished the actions of CaM–wild-type, CaM-M, and PKA, but not CaMKII, in Ca 2+ release termination. To determine the role of the PKA site RyR2-S2030 in a physiological setting, we generated a novel mouse model harboring the S2030L mutation. Using confocal Ca 2+ imaging, we found that isoproterenol and CaM-M suppressed pacing-induced Ca 2+ alternans and accelerated Ca 2+ transient recovery in intact working hearts, whereas CaM–wild-type exerted an opposite effect. The impact of isoproterenol was partially and fully reversed by the PKA inhibitor H89 and the CaMKII inhibitor KN93 individually and together, respectively. S2030L abolished the impact of CaM–wild-type, CaM-M, and H89-sensitive component, but not the KN93-sensitive component, of isoproterenol. These data demonstrate, for the first time, that the PKA phosphorylation site RyR-S2030 is an important determinant of PKA-regulated, CaM-dependent Ca 2+ release termination, and Ca 2+ alternans. Download figure Download PowerPoint

KCNE2 Protein S98 Phosphorylation in Heart of Old SHR Rats Detected by Point Mutagenesis

Functional Consequence of Protein Kinase A-dependent Phosphorylation of the Cardiac Ryanodine Receptor: Sensitization of Store Overload-Induced Ca2+ Release.

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

Expression of MKP-1 in myocardium of hypertensive rat at different ages and its effect on myocardial hypertrophy

Alterations in gene expression of sarcoplasmic reticulum Ca2+-ATPase and phospholamban detected by RNA array in spontaneously hypertensive rats

Characterization of a Novel PKA Phosphorylation Site, Serine-2030, Reveals No PKA Hyperphosphorylation of the Cardiac Ryanodine Receptor in Canine Heart Failure.

Abstract P2070: The Microprotein Another-Regulin Regulates Serca2a In Response To Neurohormonal Signaling

[Change of Mitogen-Activated Protein Kinase Phosphatase-1 in Heart and Aorta of SHR and Its Effect on Proliferation of Vascular Smooth Muscle Cells Stimulated by Angiotensin II].

Protein Phosphatase 2A Effectively Modulates Basal L-type Ca2+ Current by Dephosphorylating Cav1.2 at Serine 1866 in Mouse Cardiac Myocytes

Alterations of myocardial ultrastructure and gene expression of calcium handling proteins in diabetic rat heart]

The Changes of Mitogen-Activated Protein Kinase and Mitogen-Activated Protein Kinase Phosphatase-1 in Cardiac and Vascular Smooth Muscles of Hypertensive Rats

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2

Effect of R302Q Mutation on Glycogen and Calcium Ion Homeostasis of Cardiomyocytes in PRKAG2 Cardiac ;Syndrome

[Changes of Mitogen-Activated Protein Kinase Activity in Cardiac Tissues, Ang II and Cardiac Hypertrophy in Spontaneously Hypertensive Rats].

RyR2 Serine-2030 PKA Site Governs Ca2+ Release Termination and Ca2+ Alternans

Characterization Of A Novel Cardiac Isoform Of The Cell Cycle-Related Kinase

Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction

Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy

Ser-2030, but Not Ser-2808, is the Major Phosphorylation Site in Cardiac Ryanodine Receptors Responding to Protein Kinase A Activation Upon Beta-Adrenergic Stimulation in Normal and Failing Hearts.

Evaluation of the dissemination of active support training in staffed community residences.

Pyruvate kinase M2 sustains cardiac mitochondrial quality surveillance in septic cardiomyopathy by regulating prohibitin 2 abundance via S91 phosphorylation